State policymakers must often take action during an emerging crisis even when evidence identifying the best policy approach is not be available. This report, Evidence-Based Policymaking Is an Iterative Process: A Case Study of Antipsychotic Use among Children in the Foster Care System, explores successful state responses to dramatic increases in antipsychotic prescription rates in Medicaid-enrolled children […]
Author Archive for: johanna-butler
About Johanna Butler
Johanna Butler joined NASHP’s Emerging Policy Issues team in June 2018. She is involved with several projects related to lowering the cost of health care, focusing specifically on health system costs and prescription drug prices. She has also worked on advancing evidence-based policymaking through patient-centered outcomes research. Prior to joining NASHP, Johanna was an intern in the ranking member’s health policy office of the Senate Committee on Health, Education, Labor, and Pensions. She has also worked as the Lloyd Meeds Policy Fellow at K&L Gates and interned in the White House Office of Cabinet Affairs. Johanna graduated from American University in 2018 with an interdisciplinary studies degree focused on communications, law, economics, and government, and holds a certificate in Advanced Leadership Studies from the School of Public Affairs.
Entries by Johanna Butler
Email Johanna Butler joined NASHP in June 2018 as a research analyst with the Emerging Policy Issues team. She is involved with several projects related to lowering the cost of prescription drug prices and advancing evidence-based policymaking through patient-centered outcomes research. Prior to joining NASHP, Johanna was an intern in the ranking member’s health policy […]
Telehealth– using telecommunications to improve patient care – has the potential to improve health care access and quality, especially in rural and medically-underserved areas. But inconsistent public and private insurance coverage and other challenges have hindered implementation of this promising health care tool. The National Academy for State Health Policy’s (NASHP) Patient-Centered Outcomes Research Workgroup […]
The Centers for Medicare & Medicaid Services (CMS) had a mixed response to two states’ innovative efforts to control Medicaid drug costs in June. The agency denied Massachusetts’ 1115 waiver request to create a closed Medicaid drug formulary, but it approved Oklahoma’s State Plan Amendment that authorizes supplemental rebates for value-based purchasing arrangements with pharmaceutical […]